You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

universal CAR-T(UCAR-T)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B-ALL
  • UCAR-T Cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 7, 2022

B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)

Recruiting
  • B-Cell Leukemia
  • B Cell Lymphoma
  • anti-CD19 UCAR-T injection
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Apr 21, 2022

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

T-cell Leukemia, T-cell Lymphoma Trial in ChongQing (CD7 UCAR-T cells, Fludarabine, Cytoxan)

Recruiting
  • T-cell Leukemia
  • T-cell Lymphoma
  • CD7 UCAR-T cells
  • +3 more
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Jun 21, 2021

Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Recruiting
  • Acute Myeloid Leukemia
  • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

Recruiting
  • Advanced Glioma
  • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Targeted IL-13 Rα2 UCAR-T cell injection
  • Targeted B7-H3 UCAR-T cell injection
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Mar 2, 2023

B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

Recruiting
  • B-Cell Lymphoblastic Leukemia/Lymphoma
  • Anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +3 more
  • Universal CD7-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 17, 2023

B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

Recruiting
  • B Cell Malignancies
  • Universal CD19-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))

Recruiting
  • Advanced Solid Tumors
  • Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023

Systemic Lupus Erythematosus Trial (CD19 Universal CAR-?d T Cells)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • CD19 Universal CAR-γδ T Cells
  • (no location specified)
Oct 24, 2023

Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • +5 more
  • BRL-301
  • Shanghai, Shanghai, China
    Shanghai ChangZheng hospital
May 7, 2023

Systemic Lupus Erythematosus (SLE) Trial (BRL-301)

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • BRL-301
  • (no location specified)
Aug 13, 2023

B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • B-ALL
  • U-CAR-T Cells (LstCAR019)
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

Withdrawn
  • B-cell Lymphoma
  • B-cell Leukemia
  • anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

Safety and Efficacy of TCR-like CAR-T Trial in Nanjing (TCR-like CAR-T)

Recruiting
  • Safety and Efficacy of TCR-like CAR-T
  • TCR-like CAR-T
  • Nanjing, Jiangsu, China
    Zhongda hospital
Jul 26, 2023

Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

Recruiting
  • Multiple Myeloma
  • APRIL-BAFF-Bicephali CAR-T cells
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 14, 2023

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Not yet recruiting
  • Lymphoma
  • Chimeric Antigen Receptor
  • (no location specified)
Oct 24, 2023

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Taiyuan, Shanxi, China
  • +1 more
Aug 24, 2023

T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

Recruiting
  • T-Cell Acute Lymphocytic Leukemia
  • CD7 CAR-T
  • Langfang, Hebei, China
    Hebei Yanda Hospital
Jun 26, 2023

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

Recruiting
  • Pancreas Cancer
  • +3 more
  • CAR-T cells
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Mar 10, 2023

T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

Withdrawn
  • T-cell Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • Target CD7 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Nov 23, 2022